Larvol Delta - Viracta-Therapeutics-Announces-Interim-Data-from-Phase-1b2-Clinical-Trial-of-Nanaval-in-Patients-with-EpsteinBarr-VirusPositive-Solid-Tumors-that-Show-Conrmed-Tumor-Responses-at-Higher-Dose-Levels

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2023/12/04/2790002/0/en/Viracta-Therapeutics-Announces-Interim-Data-from-Phase-1b-2-Clinical-Trial-of-Nana-val-in-Patients-with-Epstein-Barr-Virus-Positive-Solid-Tumors-that-Show-Confirmed-Tumor-Responses.html

Dec 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next